 | • レポートコード：QY20ST-07545 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の抗体医薬品市場について種類別（モノクローナル抗体、抗体薬物複合体、ポリクローナル抗体）、用途別（ Central Nervous System (CNS) Disorders Cancers Autoimmune Disorders Cardiovascular Diseases ）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗体医薬品市場の概要 ・世界の主要地域別抗体医薬品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗体医薬品市場規模2015-2026：種類別（モノクローナル抗体、抗体薬物複合体、ポリクローナル抗体） ・世界の抗体医薬品市場規模2015-2026：用途別（ Central Nervous System (CNS) Disorders Cancers Autoimmune Disorders Cardiovascular Diseases ） ・抗体医薬品の北米市場規模2015-2020 ・抗体医薬品のヨーロッパ市場規模2015-2020 ・抗体医薬品の中国市場規模2015-2020 ・抗体医薬品の日本市場規模2015-2020 ・抗体医薬品の東南アジア市場規模2015-2020 ・抗体医薬品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・抗体医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗体医薬品の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Antibody Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antibody Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antibody Drugs industry.
Based on our recent survey, we have several different scenarios about the Antibody Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Antibody Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Antibody Drugs Scope and Market Size
The global Antibody Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antibody Drugs market is segmented into
Monoclonal Antibodies
Antibody-Drug Conjugates
Polyclonal Antibodies
Segment by Application, the Antibody Drugs market is segmented into
Central Nervous System (CNS) Disorders
Cancers
Autoimmune Disorders
Cardiovascular Diseases
The Antibody Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Antibody Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antibody Drugs Market Share Analysis
Antibody Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibody Drugs business, the date to enter into the Antibody Drugs market, Antibody Drugs product introduction, recent developments, etc.
The major vendors covered:
Novartis
Amgen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson & Johnson
AbbVie
Eli Lilly
Pfizer
Bayer
GlaxoSmithKline
Sanofi
1 Antibody Drugs Market Overview
1.1 Antibody Drugs Product Scope
1.2 Antibody Drugs Segment by Type
1.2.1 Global Antibody Drugs Sales by Type (2020-2026)
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug Conjugates
1.2.4 Polyclonal Antibodies
1.3 Antibody Drugs Segment by Application
1.3.1 Global Antibody Drugs Sales Comparison by Application (2020-2026)
1.3.2 Central Nervous System (CNS) Disorders
1.3.3 Cancers
1.3.4 Autoimmune Disorders
1.3.5 Cardiovascular Diseases
1.4 Antibody Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Antibody Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Antibody Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Antibody Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Antibody Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Antibody Drugs Industry
1.5.1.1 Antibody Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Antibody Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Antibody Drugs Players to Combat Covid-19 Impact
2 Antibody Drugs Estimate and Forecast by Region
2.1 Global Antibody Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Antibody Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Antibody Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Antibody Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Antibody Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Antibody Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Antibody Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Antibody Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Antibody Drugs Estimates and Projections (2015-2026)
2.4.3 China Antibody Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Antibody Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Antibody Drugs Estimates and Projections (2015-2026)
2.4.6 India Antibody Drugs Estimates and Projections (2015-2026)
3 Global Antibody Drugs Competition Landscape by Players
3.1 Global Top Antibody Drugs Players by Sales (2015-2020)
3.2 Global Top Antibody Drugs Players by Revenue (2015-2020)
3.3 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drugs as of 2019)
3.4 Global Antibody Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Antibody Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Antibody Drugs Players (Opinion Leaders)
4 Global Antibody Drugs Market Size by Type
4.1 Global Antibody Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Antibody Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Antibody Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Antibody Drugs Price by Type (2014-2020)
4.2 Global Antibody Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Antibody Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Antibody Drugs Price Forecast by Type (2021-2026)
5 Global Antibody Drugs Market Size by Application
5.1 Global Antibody Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Antibody Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Antibody Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Antibody Drugs Price by Application (2015-2020)
5.2 Global Antibody Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Antibody Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody Drugs Price Forecast by Application (2021-2026)
3 North America Antibody Drugs Market Facts & Figures
3.2 North America Antibody Drugs Sales Market Share by Company (2015-2020)
3.3 North America Antibody Drugs Sales Market Share by Type (2015-2020)
3.4 North America Antibody Drugs Sales Market Share by Application (2015-2020)
4 Europe Antibody Drugs Market Facts & Figures
4.2 Europe Antibody Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Antibody Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Antibody Drugs Sales Market Share by Application (2015-2020)
5 China Antibody Drugs Market Facts & Figures
5.2 China Antibody Drugs Sales Market Share by Company (2015-2020)
5.3 China Antibody Drugs Sales Market Share by Type (2015-2020)
5.4 China Antibody Drugs Sales Market Share by Application (2015-2020)
6 Japan Antibody Drugs Market Facts & Figures
6.2 Japan Antibody Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Antibody Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Antibody Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Antibody Drugs Market Facts & Figures
7.2 Southeast Asia Antibody Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Antibody Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Antibody Drugs Sales Market Share by Application (2015-2020)
8 India Antibody Drugs Market Facts & Figures
8.2 India Antibody Drugs Sales Market Share by Company (2015-2020)
8.3 India Antibody Drugs Sales Market Share by Type (2015-2020)
8.4 India Antibody Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Antibody Drugs Business
12.1 Novartis
12.1.1 Novartis Antibody Drugs Corporation Information
12.1.2 Novartis Antibody Drugs Business Overview and Total Revenue
12.1.3 Novartis Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Antibody Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Amgen
12.2.1 Amgen Antibody Drugs Corporation Information
12.2.2 Amgen Antibody Drugs Business Overview and Total Revenue
12.2.3 Amgen Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Amgen Antibody Drugs Products Offered
12.2.5 Amgen Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Antibody Drugs Corporation Information
12.3.2 Bristol-Myers Squibb Antibody Drugs Business Overview and Total Revenue
12.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bristol-Myers Squibb Antibody Drugs Products Offered
12.3.5 Bristol-Myers Squibb Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Antibody Drugs Corporation Information
12.4.2 F. Hoffmann-La Roche Antibody Drugs Business Overview and Total Revenue
12.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 F. Hoffmann-La Roche Antibody Drugs Products Offered
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Antibody Drugs Corporation Information
12.5.2 Johnson & Johnson Antibody Drugs Business Overview and Total Revenue
12.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Antibody Drugs Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 AbbVie
12.6.1 AbbVie Antibody Drugs Corporation Information
12.6.2 AbbVie Antibody Drugs Business Overview and Total Revenue
12.6.3 AbbVie Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AbbVie Antibody Drugs Products Offered
12.6.5 AbbVie Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Antibody Drugs Corporation Information
12.7.2 Eli Lilly Antibody Drugs Business Overview and Total Revenue
12.7.3 Eli Lilly Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Eli Lilly Antibody Drugs Products Offered
12.7.5 Eli Lilly Recent Development
12.8 Pfizer
12.8.1 Pfizer Antibody Drugs Corporation Information
12.8.2 Pfizer Antibody Drugs Business Overview and Total Revenue
12.8.3 Pfizer Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer Antibody Drugs Products Offered
12.8.5 Pfizer Recent Development
12.9 Bayer
12.9.1 Bayer Antibody Drugs Corporation Information
12.9.2 Bayer Antibody Drugs Business Overview and Total Revenue
12.9.3 Bayer Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bayer Antibody Drugs Products Offered
12.9.5 Bayer Recent Development
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Antibody Drugs Corporation Information
12.10.2 GlaxoSmithKline Antibody Drugs Business Overview and Total Revenue
12.10.3 GlaxoSmithKline Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 GlaxoSmithKline Antibody Drugs Products Offered
12.10.5 GlaxoSmithKline Recent Development
12.11 Sanofi
12.11.1 Sanofi Antibody Drugs Corporation Information
12.11.2 Sanofi Antibody Drugs Business Overview and Total Revenue
12.11.3 Sanofi Antibody Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sanofi Antibody Drugs Products Offered
12.11.5 Sanofi Recent Development
13 Antibody Drugs Manufacturing Cost Analysis
13.1 Antibody Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antibody Drugs
13.4 Antibody Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antibody Drugs Distributors List
14.3 Antibody Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antibody Drugs Sales (mg) Growth Rate by Type (2020-2026)
Table 2. Global Antibody Drugs Sales (mg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Antibody Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Antibody Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Antibody Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Antibody Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Antibody Drugs Sales (mg) by Region (2015-2020)
Table 10. Global Antibody Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Antibody Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Antibody Drugs Revenue Share by Region (2015-2020)
Table 13. Global Antibody Drugs Sales (mg) Forecast by Region (2021-2026)
Table 14. Global Antibody Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Antibody Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Antibody Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Antibody Drugs (mg) of Key Companies (2015-2020)
Table 18. Global Antibody Drugs Sales Share by Company (2015-2020)
Table 19. Global Antibody Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Antibody Drugs Revenue Share by Company (2015-2020)
Table 21. Global Antibody Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drugs as of 2019)
Table 22. Global Antibody Drugs Average Price (USD/mg) of Key Company (2015-2020)
Table 23. Manufacturers Antibody Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Antibody Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Antibody Drugs Players
Table 27. Global Antibody Drugs Sales (mg) by Type (2015-2020)
Table 28. Global Antibody Drugs Sales Share by Type (2015-2020)
Table 29. Global Antibody Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Antibody Drugs Price (mg) by Type (2015-2020)
Table 31. Global Antibody Drugs Sales Share by Type (2021-2026)
Table 32. Global Antibody Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Antibody Drugs Revenue Share by Type (2021-2026)
Table 34. Global Antibody Drugs Price (mg) by Type (2021-2026)
Table 35. Global Antibody Drugs Sales (mg) by Application (2015-2020)
Table 36. Global Antibody Drugs Sales Share by Application (2015-2020)
Table 37. Global Antibody Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Antibody Drugs Price (mg) by Application (2015-2020)
Table 39. Global Antibody Drugs Sales (mg) by Application (2021-2026)
Table 40. Global Antibody Drugs Sales Share by Application (2021-2026)
Table 41. Global Antibody Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Antibody Drugs Revenue Share by Application (2021-2026)
Table 43. Global Antibody Drugs Price (mg) by Application (2021-2026)
Table 44. United States Antibody Drugs Sales (mg) by Company (2015-2020)
Table 45. United States Antibody Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Antibody Drugs Sales (mg) by Type (2015-2020)
Table 47. United States Antibody Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Antibody Drugs Sales (mg) by Application (2015-2020)
Table 49. United States Antibody Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Antibody Drugs Sales (mg) by Company (2015-2020)
Table 51. Europe Antibody Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Antibody Drugs Sales (mg) by Type (2015-2020)
Table 53. Europe Antibody Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Antibody Drugs Sales (mg) by Application (2015-2020)
Table 55. Europe Antibody Drugs Sales Market Share by Type (2015-2020)
Table 56. China Antibody Drugs Sales (mg) by Company (2015-2020)
Table 57. China Antibody Drugs Sales Market Share by Company (2015-2020)
Table 58. China Antibody Drugs Sales (mg) by Type (2015-2020)
Table 59. China Antibody Drugs Sales Market Share by Type (2015-2020)
Table 60. China Antibody Drugs Sales (mg) by Application (2015-2020)
Table 61. China Antibody Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Antibody Drugs Sales (mg) by Company (2015-2020)
Table 63. Japan Antibody Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Antibody Drugs Sales (mg) by Type (2015-2020)
Table 65. Japan Antibody Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Antibody Drugs Sales (mg) by Application (2015-2020)
Table 67. Japan Antibody Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Antibody Drugs Sales (mg) by Company (2015-2020)
Table 69. Southeast Asia Antibody Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Antibody Drugs Sales (mg) by Type (2015-2020)
Table 71. Southeast Asia Antibody Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Antibody Drugs Sales (mg) by Type (2015-2020)
Table 73. Southeast Asia Antibody Drugs Sales Market Share by Application (2015-2020)
Table 74. India Antibody Drugs Sales (mg) by Company (2015-2020)
Table 75. India Antibody Drugs Sales Market Share by Company (2015-2020)
Table 76. India Antibody Drugs Sales (mg) by Type (2015-2020)
Table 77. India Antibody Drugs Sales Market Share by Type (2015-2020)
Table 78. India Antibody Drugs Sales (mg) by Application (2015-2020)
Table 79. India Antibody Drugs Sales Market Share by Application (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 83. Novartis Antibody Drugs Product
Table 84. Novartis Recent Development
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Business Overview
Table 87. Amgen Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 88. Amgen Antibody Drugs Product
Table 89. Amgen Recent Development
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Business Overview
Table 92. Bristol-Myers Squibb Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Antibody Drugs Product
Table 94. Bristol-Myers Squibb Recent Development
Table 95. F. Hoffmann-La Roche Corporation Information
Table 96. F. Hoffmann-La Roche Description and Business Overview
Table 97. F. Hoffmann-La Roche Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 98. F. Hoffmann-La Roche Antibody Drugs Product
Table 99. F. Hoffmann-La Roche Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Antibody Drugs Product
Table 104. Johnson & Johnson Recent Development
Table 105. AbbVie Corporation Information
Table 106. AbbVie Description and Business Overview
Table 107. AbbVie Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 108. AbbVie Antibody Drugs Product
Table 109. AbbVie Recent Development
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 113. Eli Lilly Antibody Drugs Product
Table 114. Eli Lilly Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 117. Pfizer Description and Business Overview
Table 118. Pfizer Antibody Drugs Product
Table 119. Pfizer Recent Development
Table 120. Bayer Corporation Information
Table 121. Bayer Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 122. Bayer Description and Business Overview
Table 123. Bayer Antibody Drugs Product
Table 124. Bayer Recent Development
Table 125. GlaxoSmithKline Corporation Information
Table 126. GlaxoSmithKline Description and Business Overview
Table 127. GlaxoSmithKline Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 128. GlaxoSmithKline Antibody Drugs Product
Table 129. GlaxoSmithKline Recent Development
Table . Sanofi Corporation Information
Table . Sanofi Description and Business Overview
Table . Sanofi Antibody Drugs Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table . Sanofi Antibody Drugs Product
Table . Sanofi Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Antibody Drugs Distributors List
Table 138. Antibody Drugs Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Drugs Product Picture
Figure 2. Global Antibody Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antibody Drugs Market Share by Application in 2020 & 2026
Figure 6. Central Nervous System (CNS) Disorders Examples
Figure 7. Cancers Examples
Figure 8. Autoimmune Disorders Examples
Figure 9. Cardiovascular Diseases Examples
Figure 10. Global Antibody Drugs Sales (mg) Growth Rate (2015-2026)
Figure 11. Global Antibody Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Antibody Drugs Price Trends Growth Rate (2015-2026) (USD/mg)
Figure 13. Global Antibody Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Antibody Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Antibody Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Antibody Drugs Sales (mg) Growth Rate (2015-2026)
Figure 17. Europe Antibody Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Antibody Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Antibody Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Antibody Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Antibody Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Antibody Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Antibody Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Antibody Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Antibody Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Antibody Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Antibody Drugs Players Market Share by Revenue in Antibody Drugs 2015 & 2019
Figure 28. Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Antibody Drugs Revenue Share by Type (2015-2020)
Figure 30. Global Antibody Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Antibody Drugs Revenue Share by Application (2015-2020)
Figure 32. Global Antibody Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Antibody Drugs Sales Market Share by Type in 2019
Figure 34. United States Antibody Drugs Sales Market Share by Type in 2019
Figure 35. Europe Antibody Drugs Sales Market Share by Company in 2019
Figure 36. Europe Antibody Drugs Sales Market Share by Type in 2019
Figure 37. Europe Antibody Drugs Sales Market Share by Application in 2019
Figure 38. China Antibody Drugs Sales Market Share by Company in 2019
Figure 39. China Antibody Drugs Sales Market Share by Type in 2019
Figure 40. China Antibody Drugs Sales Market Share by Application in 2019
Figure 41. Japan Antibody Drugs Sales Market Share by Company in 2019
Figure 42. Japan Antibody Drugs Sales Market Share by Type in 2019
Figure 43. Japan Antibody Drugs Sales Market Share by Application in 2019
Figure 44. Southeast Asia Antibody Drugs Sales Market Share by Company in 2019
Figure 45. Southeast Asia Antibody Drugs Sales Market Share by Type in 2019
Figure 46. Southeast Asia Antibody Drugs Sales Market Share by Application in 2019
Figure 47. India Antibody Drugs Sales Market Share by Company in 2019
Figure 48. India Antibody Drugs Sales Market Share by Type in 2019
Figure 49. India Antibody Drugs Sales Market Share by Application in 2019
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Antibody Drugs
Figure 63. Manufacturing Process Analysis of Antibody Drugs
Figure 64. Antibody Drugs Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
診断用特殊抗体の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Diagnostic Specialty Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…- モノクローナル抗体治療剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Monoclonal Antibody Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 146500 million by 2025, from USD 112440 million in 2019. The Mon…
- 抗体薬物複合体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antibody-drug Conjugate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibody-drug Conjuga…
- 二重特異性抗体治療の世界市場レポート2020 Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads …
- 抗核抗体検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-Nuclear Antibody Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…